Millennium Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,750,749
| Closed | -$234K | – | 5849 |
|
|
2020
Q3 | $234K | Buy |
2,750,749
+845,793
| +44% | +$42.8M | 0.29% | 42 |
|
|
2020
Q2 | $67.5M | Buy |
1,904,956
+1,588,827
| +503% | +$46.5M | 0.09% | 194 |
|
|
2020
Q1 | $4.26M | Sell |
316,129
-843,236
| -73% | -$14.2M | 0.01% | 1454 |
|
|
2019
Q4 | $24.5M | Buy |
1,159,365
+731,481
| +171% | +$12.9M | 0.03% | 723 |
|
|
2019
Q3 | $5.67M | Buy |
427,884
+295,200
| +222% | +$4.34M | 0.01% | 1703 |
|
|
2019
Q2 | $1.84M | Buy |
+132,684
| New | +$2M | ﹤0.01% | 2455 |
|
|
2019
Q1 | – | Sell |
-2,411,970
| Closed | -$38.9M | – | 4482 |
|
|
2018
Q4 | $34.4M | Buy |
2,411,970
+1,658,191
| +220% | +$32.9M | 0.05% | 483 |
|
|
2018
Q3 | $15.7M | Sell |
753,779
-2,988,740
| -80% | -$70.8M | 0.02% | 993 |
|
|
2018
Q2 | $88.6M | Buy |
3,742,519
+956,801
| +34% | +$19.2M | 0.12% | 220 |
|
|
2018
Q1 | $40.7M | Sell |
2,785,718
-3,495,808
| -56% | -$57.1M | 0.05% | 512 |
|
|
2017
Q4 | $102M | Buy |
6,281,526
+3,376,764
| +116% | +$39.9M | 0.14% | 153 |
|
|
2017
Q3 | $40.6M | Sell |
2,904,762
-1,314,720
| -31% | -$13.1M | 0.06% | 423 |
|
|
2017
Q2 | $37.3M | Buy |
4,219,482
+2,427,332
| +135% | +$17M | 0.07% | 413 |
|
|
2017
Q1 | $11.6M | Sell |
1,792,150
-1,038,857
| -37% | -$5.26M | 0.02% | 935 |
|
|
2016
Q4 | $10.4M | Buy |
2,831,007
+1,553,213
| +122% | +$4.6M | 0.02% | 908 |
|
|
2016
Q3 | $4.15M | Buy |
1,277,794
+1,018,032
| +392% | +$2.85M | 0.01% | 1451 |
|
|
2016
Q2 | $603K | Sell |
259,762
-90,935
| -26% | -$304K | ﹤0.01% | 2398 |
|
|
2016
Q1 | $877K | Buy |
+350,697
| New | +$789K | ﹤0.01% | 2254 |
|
|
2015
Q4 | – | Sell |
-10,101
| Closed | -$17K | – | 3905 |
|
|
2015
Q3 | $17K | Sell |
10,101
-333,547
| -97% | -$851K | ﹤0.01% | 3395 |
|
|
2015
Q2 | $1.4M | Buy |
+343,648
| New | +$1.4M | ﹤0.01% | 2106 |
|
|
2014
Q4 | – | Sell |
-11,994
| Closed | -$45K | – | 4409 |
|
|
2014
Q3 | $45K | Buy |
+11,994
| New | +$40.5K | ﹤0.01% | 3602 |
|
|
2014
Q1 | – | Sell |
-95,331
| Closed | -$439K | – | 4045 |
|
|
2013
Q4 | $439K | Buy |
95,331
+42,844
| +82% | +$191K | ﹤0.01% | 2794 |
|
|
2013
Q3 | $325K | Sell |
52,487
-75,200
| -59% | -$433K | ﹤0.01% | 2812 |
|
|
2013
Q2 | $695K | Buy |
+127,687
| New | +$419K | ﹤0.01% | 2166 |
|
Millennium Management's IMMU Position: Q4 2020 in Review
Millennium Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,750,749 shares — an estimated $234K sold.
Millennium Management first reported a position in IMMU in Q2 2013 and held it in 24 quarters. The position peaked at $102M in Q4 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Millennium Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Millennium Management sold 2,750,749 Immunomedics Inc shares in Q4 2020, an estimated $234K.
- Millennium Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 24 quarters.
- Millennium Management's Immunomedics Inc position peaked at $102M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.